ICLD (ICLD) Stock Price & Analysis
ICLD (ICLD) rose 0.00% to USD 0 as of June 10, 2026 at 08:33 UTC, according to Nexqual real-time market data.
ICLD last closed at USD 0; the session ranged USD 0–0 on volume of 125 shares. Market capitalization is $94,298, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 08:33 UTC.
Key Statistics (as of June 10, 2026 at 08:33 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 125 shares |
| Market Cap | $94,298 |
| Exchange | PNK |
Technical Analysis (ICLD)
Nexqual's technical model rates ICLD "STRONG SELL" based on 0 bullish and 6 bearish signals across 124 daily candles, as of June 10, 2026 at 08:33 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 70.87 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ICLD)
Wall Street analysts rate ICLD "None", per Nexqual as of June 10, 2026 at 08:33 UTC.
| Consensus Rating | None |
|---|
Earnings (ICLD)
Source: Nexqual, June 10, 2026 at 08:33 UTC.
Financials & Fundamentals (ICLD)
| Total Revenue | $32.85M |
|---|---|
| Revenue Growth (YoY) | -54.70% |
| Gross Margin | +21.30% |
| Operating Margin | -54.84% |
| Profit Margin | -33.95% |
| Current Ratio | 0.37 |
| Total Cash | $159,000 |
| Total Debt | $8.16M |
| Free Cash Flow | $-11.35M |
Source: Nexqual, June 10, 2026 at 08:33 UTC.
Financial Health Score (ICLD)
Nexqual rates ICLD's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 08:33 UTC.
| Growth | Strong — Revenue +51% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 21%, operating -55% |
| Balance Sheet | Mixed — $159K cash vs $8M debt |
| Cash Flow | Weak — FCF negative: -$11M, burning cash |
| Efficiency | Mixed — No data |
Ownership (ICLD)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 942.99M |
| Float | 454.29M |
| Short % of Float | +0.00% |
Source: Nexqual, June 10, 2026 at 08:33 UTC.
Leadership (ICLD)
ICLD is led by Mark E. Munro (age 63), Chairman of the Board & CEO, per Nexqual as of June 10, 2026 at 08:33 UTC.
| Chairman of the Board & CEO | Mark E. Munro (age 63) |
|---|---|
| Senior Vice President of Sales & Marketing | Scott R. Davis (age 53) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LIVE | Live Ventures Incorporated | USD 9.19 | ▲ 2% |
| CDTI | CDTI Advanced Materials, Inc. | USD 0.74 | ▼ 1.33% |
| RNVA | Rennova Health, Inc. | USD 0 | ▲ 0% |
| CAPN | Cayson Acquisition Corp | USD 11.03 | ▲ 0% |
| DCTH | Delcath Systems, Inc. | USD 11.69 | ▲ 9.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 08:33 UTC. This page is informational and not investment advice.